Legend Biotech Corporation (LEGN) Financials

LEGN Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 1.8 billion 521.3 million
March 31, 2026 1.6 billion 629.0 million
Dec. 31, 2025 1.7 billion 731.6 million
Sept. 30, 2025 1.7 billion 701.7 million

LEGN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -20.9 million 17.3 million
March 31, 2026 -111.3 million 19.3 million
Dec. 31, 2025 -126.6 million 14.9 million
Sept. 30, 2025 23.8 million 15.0 million

LEGN Net Income

No data available :(

LEGN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 964.6 million - 121.8 million
March 31, 2026 834.6 million - 123.3 million
Dec. 31, 2025 948.6 million - 94.6 million
Sept. 30, 2025 992.6 million 171.9 million 95.4 million

LEGN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 ?
March 31, 2026 184.7 million
Dec. 31, 2025 184.7 million
Sept. 30, 2025 184.6 million

LEGN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 96.0 million 96.4 million 63.4 million
March 31, 2026 26.0 million 86.0 million 90.1 million 50.1 million
Dec. 31, 2025 20.9 million 101.3 million 101.2 million 64.2 million
Sept. 30, 2025 5.0 million 113.1 million 87.3 million 52.6 million

LEGN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 387.5 million 137.4 million
March 31, 2026 305.1 million 175.9 million
Dec. 31, 2025 306.4 million 123.5 million
Sept. 30, 2025 272.3 million 115.3 million

LEGN

Price: $20.37

52 week price:
16.24
38.35

Earnings Per Share: -0.49 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 302700

Market Capitalization: 3.9 billion

Links: